Petra Acquisition

General Information

(Note: In an S-1/A filing dated Sept. 21, 2020, this blank check company changed its focus to healthcare; its previous S-1/A dated Aug. 26, 2020, stated a focus on the cannabis industry. The company announced the pricing of its IPO on Oct. 8, 2020. The IPO was priced on Oct. 7, 2020, at 7 million units, down from the terms of 7.5 million, and started trading on Oct. 8 on the NASDAQ. Updated details below.)

We intend to initially focus our search on identifying a prospective target business in the healthcare or healthcare-related industry in the United States and other developed countries. Our strategy will be to identify, acquire and, after our initial business combination, build, a healthcare or a healthcare-related business. We intend to focus our investment effort broadly across the entire healthcare industry, which encompasses services, therapeutics, devices, diagnostics and animal health and services. We intend to seek initial business combination targets with smaller enterprise values and to particularly focus on the life sciences, medical technology, digital health and technology-enabled services sectors.

Employees: 0
Founded: 2019
Contact Information
Address 5 West 21st Street, New York, NY 10010, US
Phone Number (917) 622-5800
Web Address
View Prospectus: Petra Acquisition
Financial Information
Market Cap $87.5mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol PAICU
Exchange NASDAQ
Shares (millions): 7.0
Price range $10.00 - $10.00
Est. $ Volume $70.0 mil
Manager / Joint Managers LifeSci Capital/ Ladenburg Thalmann
CO-Managers -
Expected To Trade: 10/8/2020
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change